Total Payments
$974,678
2024 Payments
$188,701
Companies
18
Transactions
333
Medicare Patients
793
Medicare Billing
$74,424
Payment Breakdown by Category
Other$490,406 (50.3%)
Consulting$416,020 (42.7%)
Travel$49,398 (5.1%)
Food & Beverage$16,523 (1.7%)
Research$1,887 (0.2%)
Education$444.17 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $490,406 | 49 | 50.3% |
| Consulting Fee | $416,020 | 54 | 42.7% |
| Travel and Lodging | $49,398 | 51 | 5.1% |
| Food and Beverage | $16,523 | 175 | 1.7% |
| Unspecified | $1,887 | 3 | 0.2% |
| Education | $444.17 | 1 | 0.0% |
Payments by Type
General
$972,791
330 transactions
Research
$1,887
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MML US, Inc. | $813,701 | 191 | $0 (2024) |
| Nuvectra Corporation | $93,166 | 45 | $0 (2018) |
| Saluda Medical Americas, Inc. | $53,007 | 44 | $0 (2024) |
| Lilly USA, LLC | $3,300 | 1 | $0 (2020) |
| BIOTRONIK NRO, Inc. | $2,376 | 17 | $0 (2024) |
| Heron Therapeutics, Inc. | $1,884 | 2 | $0 (2017) |
| Medtronic, Inc. | $1,788 | 1 | $0 (2021) |
| Abbott Laboratories | $1,559 | 14 | $0 (2024) |
| Integer Holdings Corporation | $1,000 | 1 | $0 (2022) |
| Medtronic USA, Inc. | $614.00 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $188,701 | 68 | MML US, Inc. ($179,584) |
| 2023 | $332,653 | 80 | MML US, Inc. ($307,359) |
| 2022 | $330,993 | 90 | MML US, Inc. ($307,251) |
| 2021 | $21,662 | 35 | MML US, Inc. ($19,506) |
| 2020 | $3,300 | 1 | Lilly USA, LLC ($3,300) |
| 2019 | $1,732 | 10 | Medtronic USA, Inc. ($614.00) |
| 2018 | $58,397 | 30 | Nuvectra Corporation ($57,810) |
| 2017 | $37,239 | 19 | Nuvectra Corporation ($35,356) |
All Payment Transactions
333 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2024 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $61.94 | General |
| 12/14/2024 | Ferring Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $412.67 | General |
| 12/14/2024 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $61.94 | General |
| 12/14/2024 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $61.94 | General |
| 12/13/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/02/2024 | MML US, Inc. | ReActiv8 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $21,412.90 | General |
| Category: Pain Management | ||||||
| 11/26/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/15/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $108.26 | General |
| Category: Pain Management | ||||||
| 11/09/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Not Applicable | ||||||
| 11/09/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $8.90 | General |
| Category: Pain Management | ||||||
| 11/08/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $118.09 | General |
| Category: Pain Management | ||||||
| 11/07/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/07/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $165.27 | General |
| Category: Pain Management | ||||||
| 11/07/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Travel and Lodging | Cash or cash equivalent | $88.54 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/06/2024 | MML US, Inc. | ReActiv8 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $17,000.00 | General |
| Category: Pain Management | ||||||
| 11/05/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $81.52 | General |
| Category: Pain Management | ||||||
| 10/24/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $80.20 | General |
| Category: RAPID DIAGNOSTICS | ||||||
| 10/02/2024 | MML US, Inc. | ReActiv8 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $17,361.94 | General |
| Category: Pain Management | ||||||
| 09/25/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $138.84 | General |
| Category: Not Applicable | ||||||
| 09/12/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $141.09 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/09/2024 | MML US, Inc. | ReActiv8 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $25,041.94 | General |
| Category: Pain Management | ||||||
| 09/06/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $31.35 | General |
| Category: Pain Management | ||||||
| 08/22/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $167.00 | General |
| Category: Pain Management | ||||||
| 08/17/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $249.01 | General |
| Category: Pain Management | ||||||
| 08/13/2024 | MML US, Inc. | ReActiv8 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $14,843.03 | General |
| Category: Pain Management | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Painful Diabetic Neuropathy | Medtronic, Inc. | $1,788 | 1 |
| ECAP Study | Saluda Medical Americas, Inc. | $99.50 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 82 | 110 | $42,706 | $7,578 |
| 2022 | 2 | 44 | 63 | $22,780 | $4,258 |
| 2021 | 13 | 363 | 476 | $179,149 | $34,530 |
| 2020 | 13 | 304 | 421 | $175,768 | $28,058 |
Total Patients
793
Total Services
1,070
Medicare Billing
$74,424
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 26 | 35 | $14,150 | $2,788 | 19.7% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 21 | 33 | $17,028 | $2,481 | 14.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 35 | 42 | $11,528 | $2,310 | 20.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 18 | 27 | $13,096 | $2,238 | 17.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 26 | 36 | $9,684 | $2,021 | 20.9% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Office | 2021 | 48 | 67 | $31,624 | $5,492 | 17.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 40 | 40 | $21,353 | $4,575 | 21.4% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance | Office | 2021 | 11 | 21 | $27,430 | $4,476 | 16.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 54 | 70 | $14,750 | $3,619 | 24.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 53 | 66 | $14,207 | $3,509 | 24.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $12,685 | $2,748 | 21.7% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance, single level | Office | 2021 | 16 | 21 | $14,496 | $1,889 | 13.0% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves with imaging guidance | Office | 2021 | 11 | 23 | $8,370 | $1,387 | 16.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 14 | 14 | $4,583 | $1,222 | 26.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 18 | 18 | $4,470 | $1,060 | 23.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 12 | $3,864 | $1,045 | 27.0% |
| 64494 | Injections of lower or sacral spine facet joint using imaging guidance, second level | Office | 2021 | 14 | 19 | $7,112 | $1,044 | 14.7% |
| 20553 | Injections of trigger points in 3 or more muscles | Office | 2021 | 17 | 33 | $6,006 | $946.30 | 15.8% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 16 | 24 | $5,491 | $936.97 | 17.1% |
| 77002 | Fluoroscopic guidance for insertion of needle | Office | 2021 | 16 | 24 | $2,708 | $579.36 | 21.4% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Office | 2020 | 51 | 67 | $31,624 | $5,741 | 18.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance | Office | 2020 | 12 | 18 | $26,375 | $4,300 | 16.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 62 | 78 | $16,037 | $3,307 | 20.6% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance | Office | 2020 | 24 | 29 | $19,479 | $2,877 | 14.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 44 | 63 | $12,947 | $2,747 | 21.2% |
About Dr. Christopher Gilligan, MD
Dr. Christopher Gilligan, MD is a Pain Medicine healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1871798397.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Gilligan, MD has received a total of $974,678 in payments from pharmaceutical and medical device companies, with $188,701 received in 2024. These payments were reported across 333 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($490,406).
As a Medicare-enrolled provider, Gilligan has provided services to 793 Medicare beneficiaries, totaling 1,070 services with total Medicare billing of $74,424. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Anesthesiology, Emergency Medicine
- Location Boston, MA
- Active Since 06/15/2007
- Last Updated 01/05/2026
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1871798397
Products in Payments
- ReActiv8 (Device) $813,701
- Algovita (Device) $93,166
- Evoke SCS (Device) $46,964
- Evoke (Device) $5,943
- Prospera (Device) $2,317
- HTX-011 (Drug) $1,884
- VECTRIS SURESCAN (Device) $1,788
- Adelante Peel-Away Introducer (Device) $1,000
- PROCLAIM (Device) $514.23
- Axium INS DRG IPG (Device) $444.17
- Intracept (Device) $330.74
- SPECTRA WAVEWRITER (Device) $224.65
- Proclaim IPG (Device) $193.66
- VIPER (Device) $169.73
- M6-C (Device) $167.48
- Proclaim Family of SCS IPGs (Device) $161.67
- ETERNA (Device) $160.61
- GENERAL PAIN MANAGEMENT (Device) $117.82
- ECAP (Device) $99.50
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $97.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Boston
Thomas Simopoulos, M.d, M.D
Pain Medicine — Payments: $306,803
Pain Medicine $306,803
Dr. Eduard Vaynberg, Md, MD
Pain Medicine — Payments: $49,810
Pain Medicine $49,810
Dr. Arti Ori, Md, MD
Pain Medicine — Payments: $34,626
Pain Medicine $34,626
Dr. Anne Louise Oaklander, Md Phd, MD PHD
Pain Medicine — Payments: $9,280
Pain Medicine $9,280
Dr. Erika Yih, Md, MD
Pain Medicine — Payments: $7,685
Pain Medicine $7,685
Steven Mach, Md, MD
Pain Medicine — Payments: $4,668
Pain Medicine $4,668